Skip to main content
. 2015 Dec 28;2015:412068. doi: 10.1155/2015/412068

Table 2.

Numbers of differentially methylated CpG sites in LM and LMS compared to normal metrium (NM) tissues.

Feature # of CpG probes Leiomyoma (LM) Leiomyosarcoma (LMS)
Hypermethylated (Δβ > 0.2) Hypomethylated (Δβ < −0.2) Hypermethylated (Δβ > 0.2) Hypomethylated (Δβ < −0.2)
Gene feature groups
Intergenic 115,382 4,910 (4.3%) 2,776 (2.4%) 4,533 (3.9%) 33,513 (29.0%)
TSS1500 67,542 1,841 (2.7%) 1,059 (1.6%) 1,614 (2.4%) 9,741 (14.4%)
TSS200 50,513 877 (1.7%) 415 (0.8%) 1,043 (2.1%) 3,625 (7.2%)
5′UTR and 1st exon 63,745 1,504 (2.4%) 913 (1.4%) 2,025 (3.2%) 6,383 (10.0%)
Gene body 157,160 4,539 (2.9%) 3,894 (2.5%) 7,072 (4.5%) 24,809 (15.8%)
3′UTR 17,170 382 (2.2%) 453 (2.6%) 750 (4.4%) 2,478 (14.4%)
Total 471,512 14,053 (3.0%) 9,510 (2.0%) 17,037 (3.6%) 80,549 (17.1%)

Relation to CGI
CGI 145,443 3,848 (2.6%) 884 (0.6%) 6,541 (4.5%) 6,612 (4.5%)
Shore and shelf 156,254 5,230 (3.3%) 2,960 (1.9%) 6,180 (4.0%) 26,231 (16.8%)
Open sea 169,815 4,975 (2.9%) 5,666 (3.3%) 4,316 (2.5%) 47,706 (28.1%)
Total 471,512 14,053 (3.0%) 9,510 (2.0%) 17,037 (3.6%) 80,549 (17.1%)

Outside of island, shore, and shelf.

Δβ of LM: average of the β values of three LM samples − average of the β values of three NM samples.

Δβ of LMS: average of the β values of three LMS samples − average of the β values of three NM samples.